HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
In BW Healthcare World, HRV Pharma MD & CEO Hari Kiran Chereddi outlines why API self-reliance has re-emerged as a strategic priority under Biopharma SHAKTI and what it means for India’s pharmaceutical future.
HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.
HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
India's rise in biosimilars & biologics. Full clipping + insights included.
HRV Pharma has been officially certified as a Great Place To Work® for 2025–2026, with multiple media outlets highlighting the company’s culture of trust, inclusivity, and employee empowerment.
HRV Pharma's CEO discusses how AI transforms pharmaceutical supply chains from reactive systems to anticipatory networks, ensuring continuous medicine availability through predictive intelligence.
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
HRV Global's Managing Director Hari Kiran Chereddi discusses India's transformation from volume-driven API supplier to value-oriented strategic partner, highlighting virtual pharma models and AI-driven operations.